Evolution of digital health market access in France

Published on March 6, 2024

The Digital Health (DH) solutions market in France has transformed significantly in recent years. The COVID-19 pandemic accelerated the rapid adoption of telemonitoring solutions and digital therapeutics. Our experts highlight recent access and reimbursement changes in France, positioning the country as a global leader in digital health reimbursement maturity.

In 2016, Diabeo, a telemonitoring solution in diabetes, became the first digital health app to receive a positive CNEDiMTS health technology assessment (HTA). This milestone paved the way for further innovations, such as Moovcare Poumon, a monitoring and diagnostic solution for lung cancer patients, and Diabeloop’s DBLG-1, an insulin titration software connected to a CGM and an insulin pump, to secure LPPR funding (List of Reimbursable Products and Services), respectively in 2020 and 2021. Back then, LPPR was the only common-law (i.e., broad and long-term) reimbursement pathway for patient-centric…

P&R Brief

Continue reading on website
Other news

Value-based pricing strategy

March 6, 2024

Mastering B2B sales negotiations: Essential best practices for success

March 7, 2024
The global economy has faced significant challenges over the past two years. Inflation and high interest rates have introduced uncertainty into the business climate. In this environment, mastering B2B sales negotiations is crucial for improving business performance. Our recent B2B sales study indicates that the fastest growing companies invest the most in their sales function. The best-selling sal